ETERNA THERAPEUTICS INC. - COMMON STOCK
1.0700
04-October-24 14:58:42
15 minutes delayed
Stocks
+0.1201
+12.64%
Today's range
0.9300 - 1.1100
ISIN
N/A
Source
NASDAQ
-
10 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Announces Appointment of Mahendra Rao, PhD, to its Scientific Advisory Board
08 May 2024 08:31:43 By Nasdaq GlobeNewswire
-
07 May 2024 07:00:01 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors
20 Feb 2024 07:30:00 By Nasdaq GlobeNewswire
-
03 Jan 2024 15:15:00 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer
20 Dec 2023 15:15:31 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing
14 Dec 2023 17:56:25 By Nasdaq GlobeNewswire
-
01 Nov 2023 07:30:00 By Nasdaq GlobeNewswire
-
06 Sep 2023 07:00:02 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
05 Sep 2023 07:30:49 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Announces Completion of $8.7 Million of Convertible Debt Financing
18 Jul 2023 07:00:01 By Nasdaq GlobeNewswire
-
11 Jul 2023 07:30:11 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Appoints Megan Yung as Chief Strategy Officer, General Counsel
24 May 2023 07:30:00 By Nasdaq GlobeNewswire
-
17 May 2023 07:30:53 By Nasdaq GlobeNewswire
-
04 May 2023 07:30:27 By Nasdaq GlobeNewswire
-
Eterna Therapeutics Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
02 May 2023 06:30:18 By Nasdaq GlobeNewswire
-
11 Apr 2023 07:00:01 By Nasdaq GlobeNewswire
-
Jeff Karp, Ph.D., Joins Eterna’s Scientific Advisory Board
28 Mar 2023 07:30:33 By Nasdaq GlobeNewswire
-
20 Mar 2023 15:10:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >